| |
| |
 |
| |
|
| |
|
| |
|
HONG KONG: Hong Kong Chinese medicine practitioners are collaborating with a Macau university to test what they believe is another alternative to combating the H1N1 virus.
If they are successful, the formula will be the first Chinese herbal prescription cure for H1N1.
As temperatures drop, Hong Kong health officials are bracing themselves for a second wave of H1N1 to hit the city.
Other than Tamiflu and flu jabs, Hong Kong R&D company Rorric Biotechnology believes it may be able to offer a less invasive cure to H1N1, using traditional Chinese medicine.
Dr Chow Ching-fung, chairman of Rorric Biotechnology, said: "This formula is effective in two ways. First, it combats and eliminates the virus. Second, it boosts the immune system, helping the patient to become stronger."
The formula is made up of 21 common Chinese herbs, such as honeysuckle and Bai Shu.
"Traditional Chinese medicine has a long history of being proven to have fewer side effects as it uses herbal ingredients," Dr Chow added. "Western medicine contains a mixture of chemicals from the manufacturing process, so the risks are higher."
Dr Chow said he had prescribed the formula, which is currently in powder form, to 100 patients suspected of contracting H1N1 and they have fully recovered.
Moreover, tests at the Wu Han Institute of Virology have shown that the formula is not only effective against H1N1, but also other mutated forms of Influenza A.
Rorric Biotechnology is now collaborating with the Macau University of Science and Technology to test the formula on 300 patients over four months.
The first goal is to have the drug registered in Macau. If all goes well, the team hopes the drug's success will gain the support of authorities in Hong Kong to give it the green light.
- CNA/so
|
